General
Release from Memphis Pharmaceuticals (MPCI.CA) - Company's Reply to the Central Auditing Organization Report
Published at 12 July 2026 at 07:58Memphis PharmaceuticalsRelated stock:Memphis Pharmaceuticals stockAll Memphis Pharmaceuticals disclosures
Disclosure summary
Company: Memphis Pharmaceuticals
Symbols: EGS38351C010
Reuters: MPCI.CA
Content:
Company's reply to the Central Auditing Organization Report for the period ended on 31/03/2026.
Company’s Reply to the Central Auditing Organization's Report (6,316 KB)
Symbols: EGS38351C010
Reuters: MPCI.CA
Content:
Company's reply to the Central Auditing Organization Report for the period ended on 31/03/2026.
Company’s Reply to the Central Auditing Organization's Report (6,316 KB)